Blaeschke, Franziska
Stenger, Dana
Apfelbeck, Antonia
Cadilha, Bruno L.
Benmebarek, Mohamed-Reda
Mahdawi, Jasmin
Ortner, Eva
Lepenies, Mareike
Habjan, Nicola
Rataj, Felicitas
Willier, Semjon
Kaeuferle, Theresa
Majzner, Robbie G.
Busch, Dirk H. http://orcid.org/0000-0001-8713-093X
Kobold, Sebastian
Feuchtinger, Tobias http://orcid.org/0000-0002-8517-9681
Article History
Received: 24 March 2021
Revised: 5 May 2021
Accepted: 17 May 2021
First Online: 4 June 2021
Conflict of interest
: S.K.: A patent application on PD-1-CD28 fusion protein has been filed. Multiple patent applications have been filed in the field of immuno-oncology. S.K. has licensed IP and received research support from TCR2 Inc, Boston USA. R.G.M. holds several patent applications in the area of CAR T-cell immunotherapy and is a consultant for Lyell Immunopharma, Xyphos Biosciences, Gamma Delta Therapeutics, Zai Lab, and Aptorum Group. F.B.: Patent applications have been filed in the field of immuno-oncology. All other authors declare that they have no competing interests.